Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2014

01-05-2014 | Original Article

Natural history of Sanfilippo syndrome type A

Authors: Dakota Buhrman, Kavita Thakkar, Michele Poe, Maria L. Escolar

Published in: Journal of Inherited Metabolic Disease | Issue 3/2014

Login to get access

Abstract

Objective

To describe the natural history of Sanfilippo syndrome type A.

Methods

We performed a retrospective review of 46 children (21 boys, 25 girls) with Sanfilippo syndrome type A evaluated between January 2000 and April 2013. Assessments included neurodevelopmental evaluations, audiologic testing, and assessment of growth, adaptive behavior, cognitive behavior, motor function, and speech/language skills. Only the baseline evaluation was included for patients who received hematopoietic stem cell transplantation.

Results

Median age at diagnosis was 35 months, with a median delay between initial symptoms to diagnosis of 24 months. The most common initial symptoms were speech/language delay (48 %), dysmorphology (22 %), and hearing loss (20 %). Early behavioral problems included perseverative chewing and difficulty with toilet training. All children developed sleep difficulties and behavioral changes (e.g., hyperactivity, aggression). More than 93 % of the children experienced somatic symptoms such as hepatomegaly (67 %), abnormal dentition (39 %), enlarged tongue (37 %), coarse facial features (76 %), and protuberant abdomen (43 %). Kaplan-Meier analysis showed a 60 % probability of surviving past 17 years of age.

Conclusions

Sanfilippo type A is characterized by severe hearing loss and speech delay, followed by a rapid decline in cognitive skills by 3 years of age. Significant somatic disease occurs in more than half of patients. Behavioral difficulties presented between 2 and 4 years of age during a rapid period of cognitive decline. Gross motor abilities are maintained during this period, which results in an active child with impaired cognition. Sleep difficulties are concurrent with the period of cognitive degeneration. There is currently an unacceptable delay in diagnosis, highlighting the need to increase awareness of this disease among clinicians.
Literature
go back to reference Baehner F, Schmiedeskamp C, Krummenauer F et al (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011–1017PubMedCrossRef Baehner F, Schmiedeskamp C, Krummenauer F et al (2005) Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 28:1011–1017PubMedCrossRef
go back to reference Bruininks R, Woodcock R, Weatherman R, Hill B (1996) Scales of independent behaviour-revised. Riverside, Chicago Bruininks R, Woodcock R, Weatherman R, Hill B (1996) Scales of independent behaviour-revised. Riverside, Chicago
go back to reference Crawley AC, Marshall N, Beard H et al (2011) Enzyme replacement reduces neuropathology in MPS IIIA dogs. Neurobiol Dis 43:422–434PubMedCrossRef Crawley AC, Marshall N, Beard H et al (2011) Enzyme replacement reduces neuropathology in MPS IIIA dogs. Neurobiol Dis 43:422–434PubMedCrossRef
go back to reference Elliott CD (1990) The Differential Ability Scales (DAS). The Psychological Corp, San Antonio Elliott CD (1990) The Differential Ability Scales (DAS). The Psychological Corp, San Antonio
go back to reference Folio M, Fewell R (2000) Peabody developmental motor scales, 2nd edn. Pro-Ed, Austin Folio M, Fewell R (2000) Peabody developmental motor scales, 2nd edn. Pro-Ed, Austin
go back to reference Héron B, Mikaeloff Y, Froissart R et al (2011) Incidence and natural history ofmucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A:58–68PubMedCrossRef Héron B, Mikaeloff Y, Froissart R et al (2011) Incidence and natural history ofmucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A:58–68PubMedCrossRef
go back to reference Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11:246 Kuczmarski RJ, Ogden CL, Guo SS et al (2002) 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11:246
go back to reference Langford-Smith A, Wilkinson FL, Langford-Smith KJ et al (2012) Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice. Mol Ther: J Am Soc Gene Ther 20:1610–1621CrossRef Langford-Smith A, Wilkinson FL, Langford-Smith KJ et al (2012) Hematopoietic stem cell and gene therapy corrects primary neuropathology and behavior in mucopolysaccharidosis IIIA mice. Mol Ther: J Am Soc Gene Ther 20:1610–1621CrossRef
go back to reference Malm G, Mansson JE (2010) Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period. Acta Paediatr 99:1253–1257PubMedCrossRef Malm G, Mansson JE (2010) Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period. Acta Paediatr 99:1253–1257PubMedCrossRef
go back to reference Martin HR, Poe MD, Reinhartsen D et al (2008) Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr Suppl 97:69–75PubMedCrossRef Martin HR, Poe MD, Reinhartsen D et al (2008) Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective. Acta Paediatr Suppl 97:69–75PubMedCrossRef
go back to reference Meyer A, Kossow K, Gal A et al (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120:e1255–e1261PubMedCrossRef Meyer A, Kossow K, Gal A et al (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120:e1255–e1261PubMedCrossRef
go back to reference Meyer A, Kossow K, Gal A et al (2008) The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat 29:770PubMedCrossRef Meyer A, Kossow K, Gal A et al (2008) The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Hum Mutat 29:770PubMedCrossRef
go back to reference Mullen E (1995) The mullen scales of early learning. American Guidance Service, Circle Pines Mullen E (1995) The mullen scales of early learning. American Guidance Service, Circle Pines
go back to reference Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A et al (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196–CR202PubMedCentralPubMedCrossRef Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A et al (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196–CR202PubMedCentralPubMedCrossRef
go back to reference Prasad VK, Mendizabal A, Parikh SH, Szabolcs P et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979–2989PubMedCentralPubMedCrossRef Prasad VK, Mendizabal A, Parikh SH, Szabolcs P et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979–2989PubMedCentralPubMedCrossRef
go back to reference Semel E, Wiig E, Secord W (2003) Clinical evaluation of language fundamentals, 4th edn. The Psychological Corporation, San Antonio Semel E, Wiig E, Secord W (2003) Clinical evaluation of language fundamentals, 4th edn. The Psychological Corporation, San Antonio
go back to reference Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240–252PubMedCrossRef Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240–252PubMedCrossRef
go back to reference Valstar MJ, Neijs S, Bruggenwirth HT et al (2010) Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann Neurol 68:876–887PubMedCrossRef Valstar MJ, Neijs S, Bruggenwirth HT et al (2010) Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations. Ann Neurol 68:876–887PubMedCrossRef
go back to reference Van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152–160PubMedCrossRef Van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA (1981) Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C). Clin Genet 20:152–160PubMedCrossRef
go back to reference Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 18:264–281PubMedCrossRef Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: diagnostic, clinical, and biological implications. Hum Mutat 18:264–281PubMedCrossRef
go back to reference Zimmerman I, Steiner V, Pond R (2002) Preschool language scale, 4th edn. The Psychological Corp, San Antonio Zimmerman I, Steiner V, Pond R (2002) Preschool language scale, 4th edn. The Psychological Corp, San Antonio
Metadata
Title
Natural history of Sanfilippo syndrome type A
Authors
Dakota Buhrman
Kavita Thakkar
Michele Poe
Maria L. Escolar
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2014
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9661-8

Other articles of this Issue 3/2014

Journal of Inherited Metabolic Disease 3/2014 Go to the issue